Knight Therapeutics Inc
(GUD.TO)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[TSX]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[TSX]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in thousands)
| 06-2014 | 03-2014 | |
| Assets | ||
| Current Assets | ||
| Cash & Cash Equivalents | 234,507 | 75,449 |
| Receivables | 832 | 76 |
| TOTAL | $235,353 | $75,545 |
| Non-Current Assets | ||
| PPE Net | 57 | 35 |
| Investments And Advances | 14,029 | N/A |
| Intangibles | 884 | 903 |
| Other Non-Current Assets | 10,000 | 10,000 |
| TOTAL | $24,971 | $10,938 |
| Total Assets | $260,324 | $86,483 |
| Liabilities | ||
| Current Liabilities | ||
| Accounts payable and accrued liabilities | 849 | 183 |
| Accrued Expenses | 653 | 306 |
| TOTAL | $1,502 | $2,990 |
| Non-Current Liabilities | ||
| TOTAL | $266 | $0 |
| Total Liabilities | $1,768 | $2,990 |
| Shareholders' Equity | ||
| Common Shares | 255,780 | 11,909 |
| Retained earnings | 315 | -76 |
| Other shareholders' equity | 1,711 | 71,168 |
| TOTAL | $258,556 | $83,493 |
| Total Liabilities And Equity | $260,324 | $86,483 |